文献速递泌尿生殖腹部MR

多参数磁共振成像评估肾脏肿块的前瞻性透明细胞可能性评分(ccLS)表现

Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging.
PubMed 文献 · Eur Radiol · 2020-08-08

本研究为2016年6月至2019年11月两机构回顾性队列,434例患者454个肾脏肿块在病理诊断前前瞻性赋值ccLS,评估其诊断透明细胞肾细胞癌的性能。ccLS≥4敏感度91%、PPV 87%,ccLS≤2特异度56%、NPV 94%;ccLS随评分升高PPV递增,且为独立危险因素。

要点

  • ccLS≥4诊断ccRCC的敏感度为91%(258/284),PPV为87%(258/295)。
  • ccLS≤2排除ccRCC的特异度为56%(96/170),NPV为94%(96/102)。
  • ccLS的PPV随评分递增:ccLS1 5%(3/55)至ccLS5 93%(173/186)。

核心结论

  • 多参数MRI通过ccLS可在所有临床分期中识别ccRCC,高PPV和NPV有助于临床管理决策。

研究设计与样本

  • 回顾性队列研究,2016年6月至2019年11月两机构434例患者454个肾脏肿块,术前行mpMRI并前瞻性赋值ccLS,以病理诊断为参考标准。

诊断标准与关键数值

  • ccLS≥4诊断ccRCC:敏感度91%(258/284),PPV 87%(258/295)。
  • ccLS≤2排除ccRCC:特异度56%(96/170),NPV 94%(96/102)。
  • 各评分PPV:ccLS1 5%(3/55),ccLS2 6%(3/47),ccLS3 35%(20/57),ccLS4 78%(85/109),ccLS5 93%(173/186)。

临床应用与阅片要点

  • ccLS可在病理前对肾脏肿块进行透明细胞可能性分层,高评分提示ccRCC可能性高。
  • ccLS高PPV和NPV可能有助于指导临床管理决策,包括肾肿块活检决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Solid renal masses have unknown malignant potential with commonly utilized imaging. Biopsy can offer a diagnosis of cancer but has a high non-diagnostic rate and complications. Reported use of multiparametric magnetic resonance imaging (mpMRI) to diagnose aggressive histology (i.e., clear cell renal cell carcinoma (ccRCC)) via a clear cell likelihood score (ccLS) was based on retrospective review of cT1a tumors. We aim to retrospectively assess the diagnostic performance of ccLS prospectively assigned to renal masses of all stages evaluated with mpMRI prior to histopathologic evaluation.

METHODS: In this retrospective cohort study from June 2016 to November 2019, 434 patients with 454 renal masses from 2 institutions with heterogenous patient populations underwent mpMRI with prospective ccLS assignment and had pathologic diagnosis. ccLS performance was assessed by contingency table analysis. The association between ccLS and ccRCC was assessed with logistic regression.

RESULTS: Mean age and tumor size were 60 ± 13 years and 5.4 ± 3.8 cm. Characteristics were similar between institutions except for patient age and race (both p < 0.001) and lesion laterality and histology (both p = 0.04). The PPV of ccLS increased with each increment in ccLS (ccLS1 5% [3/55], ccLS2 6% [3/47], ccLS3 35% [20/57], ccLS4 78% [85/109], ccLS5 93% [173/186]). Pooled analysis for ccRCC diagnosis revealed sensitivity 91% (258/284), PPV 87% (258/295) for ccLS ≥ 4, and specificity 56% (96/170), NPV 94% (96/102) for ccLS ≤ 2. Diagnostic performance was similar between institutions.

CONCLUSIONS: We confirm the optimal diagnostic performance of mpMRI to identify ccRCC in all clinical stages. High PPV and NPV of ccLS can help inform clinical management decision-making.

KEY POINTS: • The positive predictive value of the clear cell likelihood score (ccLS) for detecting clear cell renal cell carcinoma was 5% (ccLS1), 6% (ccLS2), 35% (ccLS3), 78% (ccLS4), and 93% (ccLS5). Sensitivity of ccLS ≥ 4 and specificity of ccLS ≤ 2 were 91% and 56%, respectively. • When controlling for confounding variables, ccLS is an independent risk factor for identifying clear cell renal cell carcinoma. • Utilization of the ccLS can help guide clinical care, including the decision for renal mass biopsy, reducing the morbidity and risk to patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Steinberg RL, Rasmussen RG, Johnson BA, et al. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol. 2020. PMID: 32770377. doi:10.1007/s00330-020-07093-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。